Top

Endocrine

Published in:

01-06-2020 | Dyslipidemia | Original Article

Subclinical hypothyroidism is associated with albuminuria in Japanese nondiabetic subjects

Authors: Akiko Toda, Shigeko Hara, Hiroshi Tsuji, Yasuji Arase

Published in: Endocrine | Issue 3/2020

Abstract

Purpose

Thyroid dysfunction is a risk factor of cardiovascular disease (CVD), and albuminuria is a predictor of CVD. For preventing the CVD, it is essential to clarify from which stage of thyroid dysfunction the risk of CVD starts developing. We thus investigated the association between subclinical thyroid dysfunction and albuminuria, focusing on a nondiabetic general population.

Methods

We analyzed the data of 17,221 nondiabetic subjects who underwent annual health checkups by multivariate logistic regression analyses.

Results

Compared with the subjects with euthyroidism, those with subclinical hypothyroidism presented a higher prevalence of albuminuria. By a multivariate logistic regression analysis, subclinical hypothyroidism showed a significant and independent association with the high prevalence of albuminuria compared with euthyroidism (OR 1.64, 95% CI 1.21–2.21, p = 0.001). In accord with this result, the analysis in which the lowest quartile of thyroid stimulating hormone (TSH) concentration (<0.96 µIU/mL) was used as a reference revealed that the highest quartile (>2.07 µIU/mL) had a significant and independent association with the prevalence of albuminuria (OR 1.23, 95% CI 1.01–1.51, p = 0.04). One microliter unit per milliliter increase of the serum concentration of TSH also had a significant and independent association with the prevalence of albuminuria (OR 1.07, 95% CI 1.02–1.12, p = 0.006). The association between subclinical hyperthyroidism and the prevalence of albuminuria was not significant.

Conclusion

Our data indicated that subclinical hypothyroidism was significantly and independently associated with the high prevalence of albuminuria.

A. Jabbar, A. Pingitore, S.H. Pearce, A. Zaman, G. Iervasi, S. Razvi, Thyroid hormones and cardiovascular disease. Nat. Rev. Cardiol. 14(1), 39–55 (2017). https://doi.org/10.1038/nrcardio.2016.174 CrossRefPubMed

N. Rodondi, W.P. den Elzen, D.C. Bauer, A.R. Cappola, S. Razvi, J.P. Walsh, B.O. Asvold, G. Iervasi, M. Imaizumi, T.H. Collet, A. Bremner, P. Maisonneuve, J.A. Sgarbi, K.T. Khaw, M.P. Vanderpump, A.B. Newman, J. Cornuz, J.A. Franklyn, R.G. Westendorp, E. Vittinghoff, J. Gussekloo, C. Thyroid Studies, Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304(12), 1365–1374 (2010). https://doi.org/10.1001/jama.2010.1361 CrossRefPubMedPubMedCentral

C. McQuade, M. Skugor, D.M. Brennan, B. Hoar, C. Stevenson, B.J. Hoogwerf, Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study. Thyroid 21(8), 837–843 (2011). https://doi.org/10.1089/thy.2010.0298 CrossRefPubMed

H.C. Gerstein, J.F. Mann, Q. Yi, B. Zinman, S.F. Dinneen, B. Hoogwerf, J.P. Halle, J. Young, A. Rashkow, C. Joyce, S. Nawaz, S: Yusuf, Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286(4), 421–426 (2001)CrossRef

A. Singh, S.C. Satchell, Microalbuminuria: causes and implications. Pediatr. Nephrol. 26(11), 1957–1965 (2011). https://doi.org/10.1007/s00467-011-1777-1 CrossRefPubMedPubMedCentral

T. Yasuda, H. Kaneto, A. Kuroda, T. Yamamoto, M. Takahara, T. Naka, K. Miyashita, K. Fujisawa, F. Sakamoto, N. Katakami, T.A. Matsuoka, I. Shimomura, Subclinical hypothyroidism is independently associated with albuminuria in people with type 2 diabetes. Diabetes Res. Clin. Pract. 94(3), e75–e77 (2011). https://doi.org/10.1016/j.diabres.2011.08.019 CrossRefPubMed

L. Zhang, G. Yang, Z. Su, J. Yang, Correlation between subclinical hypothyroidism and renal function in patients with diabetes mellitus. Nephrology 22(10), 790–795 (2017). https://doi.org/10.1111/nep.12852 CrossRefPubMed

M.M. El-Eshmawy, H.A. Abd El-Hafez, W.O. El Shabrawy, I.A. Abdel Aal, Subclinical hypothyroidism is independently associated with microalbuminuria in a cohort of prediabetic egyptian adults. Diabetes Metab. J. 37(6), 450–457 (2013). https://doi.org/10.4093/dmj.2013.37.6.450 CrossRefPubMedPubMedCentral

T.A. Tuliani, M. Shenoy, K. Belgrave, A. Deshmukh, S. Pant, A. Hilliard, L. Afonso, Role of microalbuminuria in predicting cardiovascular mortality in individuals with subclinical hypothyroidism. Am. J. Med. Sci. 354(3), 285–290 (2017). https://doi.org/10.1016/j.amjms.2017.04.022 CrossRefPubMed

10.

Y. Zhou, L. Ye, T. Wang, J. Hong, Y. Bi, J. Zhang, B. Xu, J. Sun, X. Huang, M. Xu, Free triiodothyronine concentrations are inversely associated with microalbuminuria. Int. J. Endocrinol. 2014, 959781 (2014). https://doi.org/10.1155/2014/959781 CrossRefPubMedPubMedCentral

11.

A. Levin, P.E. Stevens, Summary of KDIGO 2012 CKD guideline: behind the scenes, need for guidance, and a framework for moving forward. Kidney Int. 85(1), 49–61 (2014). https://doi.org/10.1038/ki.2013.444 CrossRefPubMed

12.

M.J. Huang, R.B. Wei, J. Zhao, T.Y. Su, Q.P. Li, X. Yang, X.M. Chen, Albuminuria and endothelial dysfunction in patients with non-diabetic chronic kidney disease. Med. Sci. Monit. 23, 4447–4453 (2017). https://doi.org/10.12659/msm.903660 CrossRefPubMedPubMedCentral

13.

R. Pedrinelli, G. Dell’Omo, G. Penno, M: Mariani, Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease. Vasc. Med. 6(4), 257–264 (2001). https://doi.org/10.1177/1358836x0100600410 CrossRefPubMed

14.

E. Imai, Y. Yasuda, S. Matsuo, A decade after the KDOQI CKD guidelines: a perspective from Japan. Am. J. Kidney Dis. 60(5), 729–730 (2012). https://doi.org/10.1053/j.ajkd.2012.08.025 CrossRefPubMed

15.

C.P. Wen, T.Y. David Cheng, S.P. Tsai, H.T. Chan, H.L. Hsu, C.C. Hsu, M.P. Eriksen, Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians. Public Health Nutr. 12(4), 497–506 (2009). https://doi.org/10.1017/s1368980008002802 CrossRefPubMed

16.

A.S. Levey, K.U. Eckardt, Y. Tsukamoto, A. Levin, J. Coresh, J. Rossert, D. De Zeeuw, T.H. Hostetter, N. Lameire, G. Eknoyan, Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 67(6), 2089–2100 (2005). https://doi.org/10.1111/j.1523-1755.2005.00365.x CrossRefPubMed

17.

A. Toda, S. Hara, M. Kato, H. Tsuji, Y. Arase, Association of thyrotropin concentration with chronic kidney disease in a Japanese general population cohort. Nephron 142(2), 91–97 (2019). https://doi.org/10.1159/000497326 CrossRefPubMed

18.

P. Iglesias, M.A. Bajo, R. Selgas, J.J. Diez, Thyroid dysfunction and kidney disease: an update. Rev. Endocr. Metab. Disord. 18(1), 131–144 (2017). https://doi.org/10.1007/s11154-016-9395-7 CrossRefPubMed

19.

J.L.C. Anderson, E.G. Gruppen, L. van Tienhoven-Wind, M.F. Eisenga, H. de Vries, R.T. Gansevoort, S.J.L. Bakker, R.P.F. Dullaart, Glomerular filtration rate is associated with free triiodothyronine in euthyroid subjects: comparison between various equations to estimate renal function and creatinine clearance. Eur. J. Intern. Med. 48, 94–99 (2018). https://doi.org/10.1016/j.ejim.2017.10.009 CrossRefPubMed

20.

Y. Zhang, Y. Chang, S. Ryu, J. Cho, W.Y. Lee, E.J. Rhee, M.J. Kwon, R. Pastor-Barriuso, S. Rampal, W.K. Han, H. Shin, E. Guallar, Thyroid hormone levels and incident chronic kidney disease in euthyroid individuals: the Kangbuk Samsung Health Study. Int J. Epidemiol. 43(5), 1624–1632 (2014). https://doi.org/10.1093/ije/dyu126 CrossRefPubMed

21.

S. Razvi, A. Shakoor, M. Vanderpump, J.U. Weaver, S.H. Pearce, The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J. Clin. Endocrinol. Metab. 93(8), 2998–3007 (2008). https://doi.org/10.1210/jc.2008-0167 CrossRefPubMed

22.

B.O. Asvold, L.J. Vatten, T.I. Nilsen, T. Bjoro, The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur. J. Endocrinol. 156(2), 181–186 (2007). https://doi.org/10.1530/eje.1.02333 CrossRefPubMed

23.

S. Taddei, N. Caraccio, A. Virdis, A. Dardano, D. Versari, L. Ghiadoni, A. Salvetti, E. Ferrannini, F. Monzani, Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J. Clin. Endocrinol. Metab. 88(8), 3731–3737 (2003). https://doi.org/10.1210/jc.2003-030039 CrossRefPubMed

24.

T. Nagasaki, M. Inaba, Y. Kumeda, Y. Hiura, K. Shirakawa, S. Yamada, Y. Henmi, E. Ishimura, Y. Nishizawa, Increased pulse wave velocity in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 91(1), 154–158 (2006). https://doi.org/10.1210/jc.2005-1342 CrossRefPubMed

25.

T. Nagasaki, M. Inaba, S. Yamada, K. Shirakawa, Y. Nagata, Y. Kumeda, Y. Hiura, H. Tahara, E. Ishimura, Y. Nishizawa, Decrease of brachial-ankle pulse wave velocity in female subclinical hypothyroid patients during normalization of thyroid function: a double-blind, placebo-controlled study. Eur. J. Endocrinol. 160(3), 409–415 (2009). https://doi.org/10.1530/eje-08-0742 CrossRefPubMed

26.

I. Klein, K. Ojamaa, Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344(7), 501–509 (2001). https://doi.org/10.1056/NEJM200102153440707 CrossRefPubMed

27.

F. Monzani, V. Di Bello, N. Caraccio, A. Bertini, D. Giorgi, C. Giusti, E. Ferrannini, Effect of levothyroxine on cardiac function and structure in subclinical hypothyroidism: a double blind, placebo-controlled study. J. Clin. Endocrinol. Metab. 86(3), 1110–1115 (2001). https://doi.org/10.1210/jcem.86.3.7291 CrossRefPubMed

28.

B. Biondi, S. Fazio, E.A. Palmieri, C. Carella, N. Panza, A. Cittadini, F. Bone, G. Lombardi, L. Sacca, Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 84(6), 2064–2067 (1999). https://doi.org/10.1210/jcem.84.6.5733 CrossRefPubMed

29.

B. Biondi, L. Bartalena, D.S. Cooper, L. Hegedus, P. Laurberg, G.J. Kahaly, The 2015 European thyroid association guidelines on diagnosis and treatment of endogenous subclinical hyperthyroidism. Eur. Thyroid J. 4(3), 149–163 (2015). https://doi.org/10.1159/000438750 CrossRefPubMedPubMedCentral

30.

S.H. Pearce, G. Brabant, L.H. Duntas, F. Monzani, R.P. Peeters, S. Razvi, J.L. Wemeau, 2013 ETA guideline: management of subclinical hypothyroidism. Eur. Thyroid J. 2(4), 215–228 (2013). https://doi.org/10.1159/000356507 CrossRefPubMedPubMedCentral

Title: Subclinical hypothyroidism is associated with albuminuria in Japanese nondiabetic subjects
Authors: Akiko Toda
Shigeko Hara
Hiroshi Tsuji
Yasuji Arase
Publication date: 01-06-2020
Publisher: Springer US
Keywords: Dyslipidemia
Hyperthyroidism
Hematuria
Albuminuria
Hypothyroidism
Published in: Endocrine / Issue 3/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-020-02220-9

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2020

Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19

Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonist dulaglutide in patients with type 2 diabetes: a systematic review and meta-analysis of 21 randomized controlled trials

Targeted next generation sequencing of nine osteoporosis-related genes in the Wnt signaling pathway among Chinese postmenopausal women

Incidental versus clinically diagnosed differentiated thyroid cancer in both adult and elderly subjects: histological characteristics and follow-up in a retrospective analysis from a single institution

Pemberton sign

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials